Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual Property Administration (CNIPA) Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form
Key patent strengthens proprietary position in China until August 2031 NEWTON, Mass. and GENEVA, July…